NIKKI's Efficacy in Overcoming Lyme Disease to be Presented at 2024 Leap into Health Conference
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) announced that CEO Stephen Davis will present at the 2024 Quantum Leap Into Health Conference alongside Dr. Keith Pyne, discussing NIKKI's effectiveness in treating Lyme Disease. Dr. Pyne, a medical advisor to major sports organizations including MLB, NBA, NHL, and NFL, personally experienced success with NIKKI Wearable Wellness Technology in treating his Lyme disease. After using NIKKI's Lyme Program for 10 months, Dr. Pyne's test results showed complete eradication of Lyme disease markers by May 17, 2018. Following his recovery, he joined the company's Board in 2019.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) ha annunciato che il CEO Stephen Davis presenterà alla 2024 Quantum Leap Into Health Conference insieme al Dr. Keith Pyne, discutendo l'efficacia di NIKKI nel trattamento della malattia di Lyme. Il Dr. Pyne, consulente medico per grandi organizzazioni sportive tra cui MLB, NBA, NHL e NFL, ha personalmente sperimentato un successo con la Tecnologia di Benessere Indossabile NIKKI nel trattamento della sua malattia di Lyme. Dopo aver utilizzato il Programma Lyme di NIKKI per 10 mesi, i risultati dei test del Dr. Pyne hanno mostrato l'eradicazione completa dei marker della malattia di Lyme entro il 17 maggio 2018. Dopo il suo recupero, è entrato a far parte del Consiglio della società nel 2019.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) anunció que el CEO Stephen Davis presentará en la 2024 Quantum Leap Into Health Conference junto al Dr. Keith Pyne, discutiendo la efectividad de NIKKI en el tratamiento de la enfermedad de Lyme. El Dr. Pyne, asesor médico de importantes organizaciones deportivas como MLB, NBA, NHL y NFL, experimentó personalmente el éxito con la Tecnología de Bienestar Portátil NIKKI en el tratamiento de su enfermedad de Lyme. Después de usar el Programa Lyme de NIKKI durante 10 meses, los resultados de las pruebas del Dr. Pyne mostraron la erradicación completa de los marcadores de la enfermedad de Lyme para el 17 de mayo de 2018. Tras su recuperación, se unió a la Junta de la empresa en 2019.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF)는 CEO 스티븐 데이비스가 2024 Quantum Leap Into Health Conference에서 Dr. Keith Pyne와 함께 발표하며 NIKKI의 라이ム병 치료 효능에 대해 토론할 것이라고 발표했습니다. Dr. Pyne은 MLB, NBA, NHL 및 NFL와 같은 주요 스포츠 조직의 의학 고문으로 활동하며, NIKKI 웨어러블 웰니스 기술을 통해 라이ム병 치료에 성공적인 경험을 하였습니다. NIKKI의 라이姆 프로그램을 10개월간 사용한 후, Dr. Pyne의 검사 결과는 2018년 5월 17일까지 라이姆병 마커가 완전히 사라진 것으로 나타났습니다. 회복 후, 그는 2019년 회사 이사회에 합류했습니다.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) a annoncé que le PDG Stephen Davis présentera à la 2024 Quantum Leap Into Health Conference aux côtés du Dr Keith Pyne, discutant de l'efficacité de NIKKI dans le traitement de la maladie de Lyme. Le Dr Pyne, conseiller médical de grandes organisations sportives telles que la MLB, la NBA, la NHL et la NFL, a personnellement connu le succès avec la Technologie de Bien-Être Portable NIKKI dans le traitement de sa maladie de Lyme. Après avoir utilisé le Programme Lyme de NIKKI pendant 10 mois, les résultats des tests du Dr Pyne ont montré une éradication complète des marqueurs de la maladie de Lyme au 17 mai 2018. Suite à sa guérison, il a rejoint le conseil d'administration de la société en 2019.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) gab bekannt, dass CEO Stephen Davis auf der 2024 Quantum Leap Into Health Conference zusammen mit Dr. Keith Pyne präsentieren wird, um die Wirksamkeit von NIKKI bei der Behandlung von Borreliose zu diskutieren. Dr. Pyne, medizinischer Berater zu großen Sportorganisationen wie MLB, NBA, NHL und NFL, hat persönlich Erfolge mit der NIKKI Wearable Wellness-Technologie bei der Behandlung seiner Borreliose erlebt. Nach 10 Monaten Anwendung des NIKKI Borreliose-Programms zeigten die Testergebnisse von Dr. Pyne bis zum 17. Mai 2018 eine vollständige Beseitigung der Borreliose-Marker. Nach seiner Genesung trat er 2019 dem Vorstand des Unternehmens bei.
- Successful case study of NIKKI technology treating Lyme disease in a high-profile medical professional
- Association with prominent sports organizations through Dr. Pyne's credentials
- Board member recruitment resulting from product success
- None.
VANCOUVER, BC / ACCESSWIRE / December 13, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ)(OTC PINK:FRECF), a company focused on the global commercialization of its proprietary "NIKKI" Wearable Wellness Technology, is pleased to announce Founder & CEO Stephen Davis will be presenting at the 2024 Quantum Leap Into Health Conference alongside Dr. Keith Pyne, DC, about NIKKI's efficacy in overcoming Lyme Disease.
Dr Pyne's Story: Overcoming Lyme Disease with NIKKI Wellness Technology
Dr. Keith Pyne, DC is a renowned medical advisor to professional sports organizations including the MLB, NBA, NHL and NFL, as well as Olympic and collegiate athletic teams. Currently, Dr. Pyne is medical consultant to the Los Angeles Clippers, and the 2020 and 2024 World Series Champions, the Los Angeles Dodgers. Dr Pyne was a medical consultant for the 2019 NBA Championship Team, the Toronto Raptors, and was Chairman of the Medical Board from 2015 - 2019 for 2019 World Series Winners, the Washington Nationals. Dr. Pyne's methodology for helping athletes achieve peak performance is focused on a holistic approach that encompasses biomechanics and kinetics. He is also the founder of the PMotion, a predictive technology platform that helps athletes optimize physical performance.
In 2017, suffering from a variety of health symptoms and having confirmed through clinical testing that he was a carrier of Lyme disease, Dr. Pyne was introduced to NIKKI wearable Wellness Technology. Over the next 10 months, Dr. Pyne used NIKKI's Lyme Program as instructed, and re-tested periodically, monitoring his symptoms and noting that they appeared to be diminishing along with a reduction in the markers for Lyme disease. On May 17, 2018, he was astonished to find that his final test showed the markers for Lyme disease had been completely eradicated from his system. He has since become an advocate for NIKKI Wellness Technology, and joined the Company's Board in 2019.
About NIKKI Wellness Technology
NIKKI is a personal frequency-emitting device that is worn on the wrist to facilitate cell communication to optimize health outcomes. Originally developed to help sufferers of Lyme Disease improve their symptoms, NIKKI also offers a suite of frequency-enhanced Wellness Programs for everyday wellbeing. In third-party quality of life testing over an eight-week period,
The NIKKI Affiliate Program for Doctors
Frequency Exchange Founder & CEO Stephen Davis will be joining Dr. Pyne onstage at the Leap Into Health Conference to present Dr. Pyne's clinical results after using NIKKI's Lyme Program, and to discuss the intersection of frequency therapy and bioenergetics in holistic health.
The Quantum Leap Into Health Conference is a gathering of doctors and health practitioners specializing in the field of natural and holistic health, taking place December 13-15, 2024 in Orlando, Florida. Frequency Exchange will be showcasing NIKKI at its booth and demonstrating how the device works to health practitioners, as well as promoting the NIKKI Affiliate Program to doctors and health practitioners who wish to prescribe the product to patients.
About Frequency Exchange Corp.
Based in British Columbia, Canada, Frequency Exchange Corp., throughits wholly owned subsidiary FREmedica Technologies Inc. ("FREmedica") is focused on the global commercialization of "NIKKI", a Wellness Technology device delivering frequency-enhanced Wellness Programs. NIKKI was initially developed to deliver a specialized Lyme support program designed to help people struggling with Lyme disease. Today, NIKKI also delivers Wellness Programs to assist with issues including sleep, pain, energy, immunity, and more. Learn more at frequencyexchangecorp.com.
About NIKKI Wellness Technology:
NIKKI delivers Wellness Programs to restore and improve communication in the network of trillions of cells that make up the human body. Strong cell communication is essential to good health. Health can be disrupted by physical, mental and emotional trauma. For example, poor sleep can be a symptom of pain, stress, and fatigue stemming from poor cell communication. NIKKI delivers specific frequencies into the body for the purpose of restoring proper cell function. Categories of Wellness Programs continue to grow. NIKKI Wellness Technology combined with frequency-based Wellness Programs is the result of years of development and experimentation with advanced bioenergetic technology. In third-party quality-of-life testing over an eight-week period, NIKKI was proven to provide an unprecedented level of benefits ranging from better sleep and reduced pain to less anxiety and greater energy, with
"NIKKI" simply means "Victor of the People" bringing wellness programs to all walks of life.
For more information, please contact:
Frequency Exchange Corp. | FREmedica Technologies Inc. |
Cautionary Note Regarding Forward-Looking Information
Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the trading date of the Company's common shares on the Exchange. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings areavailable under the Company's profile on SEDAR at: www.sedar.com.
Neither the Exchange nor its Regulation Services Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Frequency Exchange Corp.
View the original press release on accesswire.com
FAQ
How effective was NIKKI Wearable Wellness Technology in treating Dr. Pyne's Lyme disease (FRECF)?
What medical credentials does Dr. Keith Pyne bring to Frequency Exchange Corp (FRECF)?
When will FRECF present its Lyme disease treatment findings?
How long did it take for NIKKI's Lyme Program to show results for FRECF board member Dr. Pyne?
